-
Vetter Wins Best Managed Companies Award 2024
PharmaSources
May 30, 2024
Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has once again been awarded the Best Managed Companies Award, marking its fifth consecutive win.
-
On the Path to Net Zero: Vetter Achieves New Sustainability Goals in 2023
PharmaSources
May 09, 2024
Alongside its dynamic growth, Vetter announced that it achieved its sustainability goals for 2023.
-
Vetter Contributes to Commercial Launches of Eight Customer Products in 2023
PharmaSources
February 18, 2024
February 14, 2024 Vetterannounces the successful commercialization of eight customer drug products as of the completion of 2023.
-
Vetter Introduces the Next Evolution of the V-OVS® Syringe Closure System
PharmaSources
January 14, 2025
Vetter has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe closure system.
-
Vetter Performs Extraordinarily with Six Wins in the 12th Annual CDMO Leadership Awards
PharmaSources
April 04, 2023
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), earned the esteemed 2023 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service.
-
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
PharmaSources
February 02, 2023
Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development
-
Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration
b3cnewswire
March 30, 2022
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations...
-
Vetter’s New Clinical Manufacturing Site Now Officially Authorized
B3Cnewswire
January 20, 2022
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has received the manufacturing authorization for its new site in Rankweil, Austria.
-
Vetter Receives Manufacturing Authorization for New Site
contractpharma
January 19, 2022
First customer audits already completed.
-
Vetter Wins Frost & Sullivan’s 2021 Global Customer Value Leadership Award, and Looks Back on a Stable Year Under Ongoing Pandemic Circumstances
B3Cnewswire
December 08, 2021
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has been awarded the Frost & Sullivan's 2021 Global Customer Value Leadership Award in the aseptic fill & finish market...